chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dehydration, Dyspnoea, Echocardiogram, Electrocardiogram normal, Hypoxia
Clinical narrative: Hospitalized (11/1/21);  COVID-19 positive (11/1/21); fully vaccinated  Discharge Provider: MD Primary Care Provider: DO Admission Date: 11/2/2021 Discharge Date: 11/4/2021 PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 69 y.o. male  with pmhx of OSA on cpap, CAD s/p CABG and recent PCI in May on asa and plavix, HFpEF on torsemide, T2DM not on insulin, hx amyloidosis, HTN. He presented to the hospital for chief complaint of worsening SOB and chest discomfort. He was admitted for Elevated troponins and chest discomfort in the setting of dehydration and a COVID positive test.  Came from ER with chest discomfort and shortness of breath.  Patient was recently found to be COVID positive.  He is fully vaccinated but has not received a booster yet.  Chest angiogram thorax did reveal a right middle lobe pneumonia and was negative for PE.  Case was discussed with Cardiology given elevated troponin. They recommended heparin drip and transfer to another facility.  There was discussion about possible AFib, patient was given multiple IV Cardizem doses at facility before transfer to other facility.  At other facility, cardiology was consulted and thought this was only demand ischemia with his unchanged unremarkable EKGs and TEE. Troponins were elevated on admission but plateaud and in the context of the overall picture, were not concerning in their opinion.  Patient was admitted for elevated oxygen requirements and had a few episodes of hypoxia dropping into 87%, usually overnight. However this was determined to be 2/2 to not being on a CPAP machine and during periods of exertion. His saturations improved considerably afterwards and he continued to saturate in the mid to low 90s on room air. After two days of improved oxygen saturations, it was determined the patient would be best served by the COVID at home program. We discussed the patients care and plans moving forward to which they agreed. All questions were answered to the best of our ability with the given data. The patient was discharged in stable condition
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocardial injury, Oxygen saturation decreased, Pneumonia, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Hospitalized (11/1/21);  COVID-19 positive (11/1/21); fully vaccinated  Discharge Provider: MD Primary Care Provider: DO Admission Date: 11/2/2021 Discharge Date: 11/4/2021 PRESENTING PROBLEM: Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 69 y.o. male  with pmhx of OSA on cpap, CAD s/p CABG and recent PCI in May on asa and plavix, HFpEF on torsemide, T2DM not on insulin, hx amyloidosis, HTN. He presented to the hospital for chief complaint of worsening SOB and chest discomfort. He was admitted for Elevated troponins and chest discomfort in the setting of dehydration and a COVID positive test.  Came from ER with chest discomfort and shortness of breath.  Patient was recently found to be COVID positive.  He is fully vaccinated but has not received a booster yet.  Chest angiogram thorax did reveal a right middle lobe pneumonia and was negative for PE.  Case was discussed with Cardiology given elevated troponin. They recommended heparin drip and transfer to another facility.  There was discussion about possible AFib, patient was given multiple IV Cardizem doses at facility before transfer to other facility.  At other facility, cardiology was consulted and thought this was only demand ischemia with his unchanged unremarkable EKGs and TEE. Troponins were elevated on admission but plateaud and in the context of the overall picture, were not concerning in their opinion.  Patient was admitted for elevated oxygen requirements and had a few episodes of hypoxia dropping into 87%, usually overnight. However this was determined to be 2/2 to not being on a CPAP machine and during periods of exertion. His saturations improved considerably afterwards and he continued to saturate in the mid to low 90s on room air. After two days of improved oxygen saturations, it was determined the patient would be best served by the COVID at home program. We discussed the patients care and plans moving forward to which they agreed. All questions were answered to the best of our ability with the given data. The patient was discharged in stable condition
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inflammation, Mobility decreased
Clinical narrative: I was not able to lift and rotate my left hand for last 6 months after my 2nd shot and I had reported to Pfizer and waited for 2 months and there was not response and then reached out my doctor and asked for help ..he mentioned it may be a inflamation and by doing exercise it will become normal and I did what doctor asked me to do so and still I have issue to lift and rotate my left arm .
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injected limb mobility decreased
Clinical narrative: I was not able to lift and rotate my left hand for last 6 months after my 2nd shot and I had reported to Pfizer and waited for 2 months and there was not response and then reached out my doctor and asked for help ..he mentioned it may be a inflamation and by doing exercise it will become normal and I did what doctor asked me to do so and still I have issue to lift and rotate my left arm .
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Nausea
Clinical narrative: Little to no symptoms for first and second dose, 3rd dose showed severe headache, swollen lymph nodes, fatigue, and nausea.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Urticaria
Clinical narrative: Local urticaria approx 3cm diameter. Pruritic. At injection site. Resolved in 1 hour after cold pack applied and  children?s Claritin given.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breath sounds abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Hospitalized (11.1.21);  COVID-19 vaccine (11.1.21);  fully vaccinated  Discharge Provider: Doctor Primary Care Provider at Discharge: Physician Assistant Admission Date: 11/1/2021 Discharge Date: 11/3/2021 PRESENTING PROBLEM: COVID-19  HOSPITAL COURSE: Patient is a 55 y.o. female with a history of inflammatory arthritis and chronic obstructive pulmonary disease, who is not oxygen dependent, presents today with increasing shortness of breath and cough. She had received 2 doses of Pfizer vaccine for COVID-19.  Patient reported onset of fever, fatigue productive cough and shortness of breath 3 days ago. She noted coughing up green sputum.  She denied any chest pain, abdominal pain, nausea or vomiting, diarrhea or urinary symptoms.  She used her home inhalers without any improvement.  She tried to get into her PCP office but they had no openings so she scheduled a tele medicine visit today.  She noted the provider instructed her to be seen in the emergency department due to her coarse lung sounds and wheezing.  She proceeded to Emergency Department for evaluation.   Patient was hypoxic at 85% on room air and placed on 1 L of oxygen to maintain sats above 90%.  Laboratory studies unremarkable. EKG showed normal sinus rhythm with nonspecific ST and T wave abnormality. No change from previous EKG. COVID-19 positive.  Chest xray demonstrated hyperinflated lungs without acute cardiopulmonary process.  She was given IV Decadron and albuterol treatments but continued to require 1 L of oxygen.  Given her continued hypoxia she was transferred via EMS to Big Rapids Hospital for further care and treatment of chronic obstructive pulmonary disease exacerbation secondary to COVID-19 Pneumonia.  Patient was weaned to room air on 11/2 though her work of breathing warranted further monitoring. On 11/3 she had some dyspnea with exertion but was feeling well at rest; she felt confident to go home.  She will be discharged in stable condition on room air with a medrol dose pack and guaifenesin.  She understands she is recommended to follow up with her PCP to ensure resolution of Covid-19 with concomitant COPD exacerbation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Dyspnoea exertional, Electrocardiogram ST-T segment abnormal
Clinical narrative: Hospitalized (11.1.21);  COVID-19 vaccine (11.1.21);  fully vaccinated  Discharge Provider: Doctor Primary Care Provider at Discharge: Physician Assistant Admission Date: 11/1/2021 Discharge Date: 11/3/2021 PRESENTING PROBLEM: COVID-19  HOSPITAL COURSE: Patient is a 55 y.o. female with a history of inflammatory arthritis and chronic obstructive pulmonary disease, who is not oxygen dependent, presents today with increasing shortness of breath and cough. She had received 2 doses of Pfizer vaccine for COVID-19.  Patient reported onset of fever, fatigue productive cough and shortness of breath 3 days ago. She noted coughing up green sputum.  She denied any chest pain, abdominal pain, nausea or vomiting, diarrhea or urinary symptoms.  She used her home inhalers without any improvement.  She tried to get into her PCP office but they had no openings so she scheduled a tele medicine visit today.  She noted the provider instructed her to be seen in the emergency department due to her coarse lung sounds and wheezing.  She proceeded to Emergency Department for evaluation.   Patient was hypoxic at 85% on room air and placed on 1 L of oxygen to maintain sats above 90%.  Laboratory studies unremarkable. EKG showed normal sinus rhythm with nonspecific ST and T wave abnormality. No change from previous EKG. COVID-19 positive.  Chest xray demonstrated hyperinflated lungs without acute cardiopulmonary process.  She was given IV Decadron and albuterol treatments but continued to require 1 L of oxygen.  Given her continued hypoxia she was transferred via EMS to Big Rapids Hospital for further care and treatment of chronic obstructive pulmonary disease exacerbation secondary to COVID-19 Pneumonia.  Patient was weaned to room air on 11/2 though her work of breathing warranted further monitoring. On 11/3 she had some dyspnea with exertion but was feeling well at rest; she felt confident to go home.  She will be discharged in stable condition on room air with a medrol dose pack and guaifenesin.  She understands she is recommended to follow up with her PCP to ensure resolution of Covid-19 with concomitant COPD exacerbation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypoxia, Incisional hernia, Laboratory test normal, Lung hyperinflation
Clinical narrative: Hospitalized (11.1.21);  COVID-19 vaccine (11.1.21);  fully vaccinated  Discharge Provider: Doctor Primary Care Provider at Discharge: Physician Assistant Admission Date: 11/1/2021 Discharge Date: 11/3/2021 PRESENTING PROBLEM: COVID-19  HOSPITAL COURSE: Patient is a 55 y.o. female with a history of inflammatory arthritis and chronic obstructive pulmonary disease, who is not oxygen dependent, presents today with increasing shortness of breath and cough. She had received 2 doses of Pfizer vaccine for COVID-19.  Patient reported onset of fever, fatigue productive cough and shortness of breath 3 days ago. She noted coughing up green sputum.  She denied any chest pain, abdominal pain, nausea or vomiting, diarrhea or urinary symptoms.  She used her home inhalers without any improvement.  She tried to get into her PCP office but they had no openings so she scheduled a tele medicine visit today.  She noted the provider instructed her to be seen in the emergency department due to her coarse lung sounds and wheezing.  She proceeded to Emergency Department for evaluation.   Patient was hypoxic at 85% on room air and placed on 1 L of oxygen to maintain sats above 90%.  Laboratory studies unremarkable. EKG showed normal sinus rhythm with nonspecific ST and T wave abnormality. No change from previous EKG. COVID-19 positive.  Chest xray demonstrated hyperinflated lungs without acute cardiopulmonary process.  She was given IV Decadron and albuterol treatments but continued to require 1 L of oxygen.  Given her continued hypoxia she was transferred via EMS to Big Rapids Hospital for further care and treatment of chronic obstructive pulmonary disease exacerbation secondary to COVID-19 Pneumonia.  Patient was weaned to room air on 11/2 though her work of breathing warranted further monitoring. On 11/3 she had some dyspnea with exertion but was feeling well at rest; she felt confident to go home.  She will be discharged in stable condition on room air with a medrol dose pack and guaifenesin.  She understands she is recommended to follow up with her PCP to ensure resolution of Covid-19 with concomitant COPD exacerbation.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Pyrexia, SARS-CoV-2 test positive, Sputum discoloured, Wheezing
Clinical narrative: Hospitalized (11.1.21);  COVID-19 vaccine (11.1.21);  fully vaccinated  Discharge Provider: Doctor Primary Care Provider at Discharge: Physician Assistant Admission Date: 11/1/2021 Discharge Date: 11/3/2021 PRESENTING PROBLEM: COVID-19  HOSPITAL COURSE: Patient is a 55 y.o. female with a history of inflammatory arthritis and chronic obstructive pulmonary disease, who is not oxygen dependent, presents today with increasing shortness of breath and cough. She had received 2 doses of Pfizer vaccine for COVID-19.  Patient reported onset of fever, fatigue productive cough and shortness of breath 3 days ago. She noted coughing up green sputum.  She denied any chest pain, abdominal pain, nausea or vomiting, diarrhea or urinary symptoms.  She used her home inhalers without any improvement.  She tried to get into her PCP office but they had no openings so she scheduled a tele medicine visit today.  She noted the provider instructed her to be seen in the emergency department due to her coarse lung sounds and wheezing.  She proceeded to Emergency Department for evaluation.   Patient was hypoxic at 85% on room air and placed on 1 L of oxygen to maintain sats above 90%.  Laboratory studies unremarkable. EKG showed normal sinus rhythm with nonspecific ST and T wave abnormality. No change from previous EKG. COVID-19 positive.  Chest xray demonstrated hyperinflated lungs without acute cardiopulmonary process.  She was given IV Decadron and albuterol treatments but continued to require 1 L of oxygen.  Given her continued hypoxia she was transferred via EMS to Big Rapids Hospital for further care and treatment of chronic obstructive pulmonary disease exacerbation secondary to COVID-19 Pneumonia.  Patient was weaned to room air on 11/2 though her work of breathing warranted further monitoring. On 11/3 she had some dyspnea with exertion but was feeling well at rest; she felt confident to go home.  She will be discharged in stable condition on room air with a medrol dose pack and guaifenesin.  She understands she is recommended to follow up with her PCP to ensure resolution of Covid-19 with concomitant COPD exacerbation.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: "Covid Arm" after booster dose only.  Red, itchy hard swelling about 2 inches below the injection site about 2x1 inches wide.  Took benadryl and advil for 2 days.  Mostly gone 6 days later.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Computerised tomogram normal, Magnetic resonance imaging head, Tinnitus, Venogram
Clinical narrative: SEVERE CONTINUOUS TINNITUS BOTH EARS- WHOOSHING RT SIDE, RUMBLING & CRICKET NOISE LEFT SIDE
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac flutter, Cardiac monitoring
Clinical narrative: Heart flutters
Age: 34.0
Sex: F
Vaccine: UNK
Symptoms: Chest pain, Headache, Hypoaesthesia oral, Pain in extremity
Clinical narrative: There is consistent pain on the left side of my chest right above my breast. I have random  pains that shoot up my left and my right arm.  I constantly have headaches throughout the day. I?m also experiencing numbness on my tongue.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Muscle aches , headache, lethargy, red swollen firm and  tender circle approximately 5 cm in diameter at injection site
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Myalgia
Clinical narrative: Muscle aches , headache, lethargy, red swollen firm and  tender circle approximately 5 cm in diameter at injection site
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Echocardiogram abnormal, Myocarditis
Clinical narrative: Went into cardiac arrest on 10/29/21 had echocardiogram done and found myocardis/micardis
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inflammation
Clinical narrative: Severe inflammatory response resulting in hamstring tear from attempt to jog (3 steps), rotator cuff injury from light weightlifting. Dr. prescribed prednisone for 5 days to relieve inflammation. Inflammatory response to exercise slowly decreased over the next 3 months, although I still have not recovered full strength.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Pallor, Tinnitus, Vision blurred
Clinical narrative: Dizzy, pale, ringing in ears, blurry vision all subsided after 20-30 min. Sore arm for 2 days.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Chest X-ray, Condition aggravated, Confusional state, Cough
Clinical narrative: Pt was 75 y.o female with history of lewy body dementia and CLL who presented at local HCF with cough and shortness of breath. Pt was confused with her dementia at baseline and did not know where she was. Daughter stated she started having a cough with shortness of breath. She states she had a chest x-ray  done per her primary provider and was started on Augmentin. This caused some GI upset and was thus stopped.  Pt had some worsening shortness of breath and her oxygen saturation dropped down to the 70s. She was therefore transferred to here from the first HCF to be  evaluated in the ER. She was fully vaccinated against Covid-19 and had both her shot at the beginning  of this year.   Pt passed at 1913 on 10/13/2021 with family at side. breathing ceased and no apical pulse noted
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Dementia, Dyspnoea, Oxygen saturation decreased, Pulse absent
Clinical narrative: Pt was 75 y.o female with history of lewy body dementia and CLL who presented at local HCF with cough and shortness of breath. Pt was confused with her dementia at baseline and did not know where she was. Daughter stated she started having a cough with shortness of breath. She states she had a chest x-ray  done per her primary provider and was started on Augmentin. This caused some GI upset and was thus stopped.  Pt had some worsening shortness of breath and her oxygen saturation dropped down to the 70s. She was therefore transferred to here from the first HCF to be  evaluated in the ER. She was fully vaccinated against Covid-19 and had both her shot at the beginning  of this year.   Pt passed at 1913 on 10/13/2021 with family at side. breathing ceased and no apical pulse noted
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory arrest
Clinical narrative: Pt was 75 y.o female with history of lewy body dementia and CLL who presented at local HCF with cough and shortness of breath. Pt was confused with her dementia at baseline and did not know where she was. Daughter stated she started having a cough with shortness of breath. She states she had a chest x-ray  done per her primary provider and was started on Augmentin. This caused some GI upset and was thus stopped.  Pt had some worsening shortness of breath and her oxygen saturation dropped down to the 70s. She was therefore transferred to here from the first HCF to be  evaluated in the ER. She was fully vaccinated against Covid-19 and had both her shot at the beginning  of this year.   Pt passed at 1913 on 10/13/2021 with family at side. breathing ceased and no apical pulse noted
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Death, Hypoxia, Interstitial lung disease
Clinical narrative: Acute and pervasive interstitial lung disease causing hypoxia requiring hospitalization to assist with oxygen needs  of 5?10L per min  Three month hospital followed by death on 08/07/21
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: X-ray
Clinical narrative: Acute and pervasive interstitial lung disease causing hypoxia requiring hospitalization to assist with oxygen needs  of 5?10L per min  Three month hospital followed by death on 08/07/21
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: Local reaction on right arm. Hot, red, hard, sore to touch. Headache, fatigue, three days later
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Local reaction
Clinical narrative: Local reaction on right arm. Hot, red, hard, sore to touch. Headache, fatigue, three days later
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Client stated, "I am starting to itch on my arms and neck. I expected this to happen because I reacted the same way to my first and second dose of Pfizer." Co Lead RN observed red scratch marks on client's neck, upper chest, and inner forearms bilaterally near elbows. Client denied symptoms of shortness of breath or difficulty swallowing. Co Lead RN recommended to client the administration of Benadryl 50 mg PO once to alleviate mild allergic reaction symptoms. Client was in agreement, Secondary RN prepared and administered Benadryl 50 mg PO once to client at 12:24 PM. At 12:26 PM first set of vitals: B/P RA 132/76, pulse 103, O2 SAT 98%. Client stated, "my heart rate is usually high. It runs between 99-103 so that is normal for me. I am seeing a cardiologist for that to be cleared for my my gallbladder surgery." Client denied drinking caffeine and denied being a smoker. Client was provided 2 water bottles and 1 gram cracker. At 12:29 PM Co Lead RN recommended for client to call father on cell phone. Co Lead RN educated client to enroll in V-SAFE and follow up with PCP within 24 hours. Co lead RN educated client on when to call 911 or go to urgent care if adverse symptoms reappeared when client got home. At 12:55 client stated, "the itching is coming and going in waves, but I am starting to feel better. I know I've taken 100-125 mg of Benadryl to my reactions in the past." Client began to have slight rash appear above left eye brow. Co lead RN educated client that Benadryl 50 mg oral medication needed 30-45 minutes to begin having affect and could only be administered once per policy. Client appeared stable and stated, "I am starting to feel better with the itching." 1:00 PM vitals retaken by Secondary RN: B/P: 147/92, pulse 95, O2 SAT 100%. At 1:15 PM Co Lead RN reassessed client and she stated, "I am fine now. I am ready to go home." Co Lead RN confirmed that father was in the parking lot of vaccination site. Left eyebrow rash was no longer visible on client. No hives nor rash on upper extremities/neck/torso on client. At 1:17 PM Co Lead RN walked with client whom had a steady gait to parking lot and witnessed client meet up with father.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death approximately 6 hours after administration. Hospice patient.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Magnetic resonance imaging head abnormal, Meningeal thickening, Neurosarcoidosis
Clinical narrative: Symptom was headache similar to prior episode of presumed neuro sarcoidosis
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Superficial vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Left leg venous thrombosis.  Presented as medial left leg pain one day after receiving her booster vaccine.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Significant hair loss. Hair started falling out in August. Comes out in clumps when I wash it.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acinetobacter bacteraemia, Acute respiratory failure, Anticoagulant therapy, Axillary vein thrombosis, Blood culture negative
Clinical narrative: 76 y.o female with h/o COPD on 2 L home oxygen, type 2 diabetes, hypertension, having been found unresponsive at HCF. With GCS 3 patient intubated, and mechanically ventilated at a local HCF. Diagnosed with COVID-19 and acinetobacter bacteremia. Right upper extremity with occlusive DVT in right brachial and basilic vein with nonocclusive thrombus in right axillary vein, initiated anticoagulation. Previous CT revealed no PE, However,  did show dilated pulmonary arteries. Repeat CT chest with contrast 09/14 revealed small amount of thrombus in left jugular and extensive chronic findings including goiter and marked enlargement of left pulmonary artery prior to previous.  Pt was transferred to another HCF for vascular surgery evaluation, advised nonsurgical, continuing anticoagulation. Pt persistently, off sedation, demonstrated no significant improvement with cognition/neurologic status. MRI brain 9/13 revealed no acute intracranial abnormally. EEG resulted abnormal with severe generalized slowing, consistent with severe encephalopathy, concern for possible epileptiform discharge prompted Neurology evaluation, provided Keppra. Pt was provided broad-spectrum antibiotics with cefepime and doxycycline, negative repeat blood cultures prompted discontinuation of antibiotics after 5 days of therapy. HCF provided counsel with family members regarding goals of care, ultimately, decision made to transition to comfort measure on the afternoon on 09/18/2021.  Pt succumbed to illness, suffered cardiopulmonary collapse as result of acute respiratory failure with hypoxemia secondary COVID-19 viral pneumonia at 1;45am on 09/29/2021
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Circulatory collapse, Cognitive disorder, Computerised tomogram thorax abnormal
Clinical narrative: 76 y.o female with h/o COPD on 2 L home oxygen, type 2 diabetes, hypertension, having been found unresponsive at HCF. With GCS 3 patient intubated, and mechanically ventilated at a local HCF. Diagnosed with COVID-19 and acinetobacter bacteremia. Right upper extremity with occlusive DVT in right brachial and basilic vein with nonocclusive thrombus in right axillary vein, initiated anticoagulation. Previous CT revealed no PE, However,  did show dilated pulmonary arteries. Repeat CT chest with contrast 09/14 revealed small amount of thrombus in left jugular and extensive chronic findings including goiter and marked enlargement of left pulmonary artery prior to previous.  Pt was transferred to another HCF for vascular surgery evaluation, advised nonsurgical, continuing anticoagulation. Pt persistently, off sedation, demonstrated no significant improvement with cognition/neurologic status. MRI brain 9/13 revealed no acute intracranial abnormally. EEG resulted abnormal with severe generalized slowing, consistent with severe encephalopathy, concern for possible epileptiform discharge prompted Neurology evaluation, provided Keppra. Pt was provided broad-spectrum antibiotics with cefepime and doxycycline, negative repeat blood cultures prompted discontinuation of antibiotics after 5 days of therapy. HCF provided counsel with family members regarding goals of care, ultimately, decision made to transition to comfort measure on the afternoon on 09/18/2021.  Pt succumbed to illness, suffered cardiopulmonary collapse as result of acute respiratory failure with hypoxemia secondary COVID-19 viral pneumonia at 1;45am on 09/29/2021
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death, Deep vein thrombosis, Electroencephalogram abnormal, Encephalopathy, Endotracheal intubation
Clinical narrative: 76 y.o female with h/o COPD on 2 L home oxygen, type 2 diabetes, hypertension, having been found unresponsive at HCF. With GCS 3 patient intubated, and mechanically ventilated at a local HCF. Diagnosed with COVID-19 and acinetobacter bacteremia. Right upper extremity with occlusive DVT in right brachial and basilic vein with nonocclusive thrombus in right axillary vein, initiated anticoagulation. Previous CT revealed no PE, However,  did show dilated pulmonary arteries. Repeat CT chest with contrast 09/14 revealed small amount of thrombus in left jugular and extensive chronic findings including goiter and marked enlargement of left pulmonary artery prior to previous.  Pt was transferred to another HCF for vascular surgery evaluation, advised nonsurgical, continuing anticoagulation. Pt persistently, off sedation, demonstrated no significant improvement with cognition/neurologic status. MRI brain 9/13 revealed no acute intracranial abnormally. EEG resulted abnormal with severe generalized slowing, consistent with severe encephalopathy, concern for possible epileptiform discharge prompted Neurology evaluation, provided Keppra. Pt was provided broad-spectrum antibiotics with cefepime and doxycycline, negative repeat blood cultures prompted discontinuation of antibiotics after 5 days of therapy. HCF provided counsel with family members regarding goals of care, ultimately, decision made to transition to comfort measure on the afternoon on 09/18/2021.  Pt succumbed to illness, suffered cardiopulmonary collapse as result of acute respiratory failure with hypoxemia secondary COVID-19 viral pneumonia at 1;45am on 09/29/2021
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Goitre, Jugular vein thrombosis, Magnetic resonance imaging head normal, Mechanical ventilation, Neurological examination
Clinical narrative: 76 y.o female with h/o COPD on 2 L home oxygen, type 2 diabetes, hypertension, having been found unresponsive at HCF. With GCS 3 patient intubated, and mechanically ventilated at a local HCF. Diagnosed with COVID-19 and acinetobacter bacteremia. Right upper extremity with occlusive DVT in right brachial and basilic vein with nonocclusive thrombus in right axillary vein, initiated anticoagulation. Previous CT revealed no PE, However,  did show dilated pulmonary arteries. Repeat CT chest with contrast 09/14 revealed small amount of thrombus in left jugular and extensive chronic findings including goiter and marked enlargement of left pulmonary artery prior to previous.  Pt was transferred to another HCF for vascular surgery evaluation, advised nonsurgical, continuing anticoagulation. Pt persistently, off sedation, demonstrated no significant improvement with cognition/neurologic status. MRI brain 9/13 revealed no acute intracranial abnormally. EEG resulted abnormal with severe generalized slowing, consistent with severe encephalopathy, concern for possible epileptiform discharge prompted Neurology evaluation, provided Keppra. Pt was provided broad-spectrum antibiotics with cefepime and doxycycline, negative repeat blood cultures prompted discontinuation of antibiotics after 5 days of therapy. HCF provided counsel with family members regarding goals of care, ultimately, decision made to transition to comfort measure on the afternoon on 09/18/2021.  Pt succumbed to illness, suffered cardiopulmonary collapse as result of acute respiratory failure with hypoxemia secondary COVID-19 viral pneumonia at 1;45am on 09/29/2021
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary artery dilatation, Scan with contrast abnormal, Unresponsive to stimuli
Clinical narrative: 76 y.o female with h/o COPD on 2 L home oxygen, type 2 diabetes, hypertension, having been found unresponsive at HCF. With GCS 3 patient intubated, and mechanically ventilated at a local HCF. Diagnosed with COVID-19 and acinetobacter bacteremia. Right upper extremity with occlusive DVT in right brachial and basilic vein with nonocclusive thrombus in right axillary vein, initiated anticoagulation. Previous CT revealed no PE, However,  did show dilated pulmonary arteries. Repeat CT chest with contrast 09/14 revealed small amount of thrombus in left jugular and extensive chronic findings including goiter and marked enlargement of left pulmonary artery prior to previous.  Pt was transferred to another HCF for vascular surgery evaluation, advised nonsurgical, continuing anticoagulation. Pt persistently, off sedation, demonstrated no significant improvement with cognition/neurologic status. MRI brain 9/13 revealed no acute intracranial abnormally. EEG resulted abnormal with severe generalized slowing, consistent with severe encephalopathy, concern for possible epileptiform discharge prompted Neurology evaluation, provided Keppra. Pt was provided broad-spectrum antibiotics with cefepime and doxycycline, negative repeat blood cultures prompted discontinuation of antibiotics after 5 days of therapy. HCF provided counsel with family members regarding goals of care, ultimately, decision made to transition to comfort measure on the afternoon on 09/18/2021.  Pt succumbed to illness, suffered cardiopulmonary collapse as result of acute respiratory failure with hypoxemia secondary COVID-19 viral pneumonia at 1;45am on 09/29/2021
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Painful, itchy, firm, hot lump at injection site that developed within a few hours of booster (third) dose
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Fatigue, Inflammation, Injection site pain
Clinical narrative: Severe pain at injection site and under arm pit for over 72 hours that OTC pain relievers cannot control. Arm pits feels inflamed. Cannot rotate or lift arm fully.   Injection site warmness, Body chills and fatigue within first 24 hours.  These side effects have subsided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Joint range of motion decreased
Clinical narrative: Severe pain at injection site and under arm pit for over 72 hours that OTC pain relievers cannot control. Arm pits feels inflamed. Cannot rotate or lift arm fully.   Injection site warmness, Body chills and fatigue within first 24 hours.  These side effects have subsided.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Pallor
Clinical narrative: Secondary RN observed client to appear pale and stating having a "tummy ache." At 12:30 Secondary RN took vitals on client: BP 100/75, pulse 73, O2 SAT 98%. Secondary RN provided client with graham crackers and apple juice. Client declined gravity chair. Client has no diagnosed medical conditions nor taking medications. At 12:45 Secondary RN observed client's color of skin on face reappear to pinkish tone. Client denied having a stomach ache any longer. Co Lead RN provided an Ice Pack to client and observed him to be stable. Client's mother stated her and her husband would be driving home nearby locally. Secondary RN educated client's parents to follow up with child's PCP and when to call emergency services if adverse symptoms reappeared. At 12:47 PM client and family exited facility together. Client left with steady gait.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness
Clinical narrative: brief episode of bilateral upper extremity weakness and numbness.   symptoms completely resolved after approximately 10-15 minutes. Completely asymptomatic since this event.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: PATIENT CAME TO GET A MODERNA BOOSTER (0.25 ML) DOSE, BUT RECEIVED A FULL DOSE OF MODERNA INSTEAD (0.5ML)
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: PATIENT CAME TO GET A MODERNA BOOSTER (0.25ML) DOSE, BUT RECEIVED A FULL DOSE OF MODERNA ML)
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Pt arrived with his grandmother to recieve a pediatric pfizer vaccination. Mother, ill at home, gave phone consent per policy. Pt inadvertantly was given an incorrect vaccination, receiving Moderna 025ml NOT Pfizer. When discrepancy was found, Medical Director was contacted and I called pt. Mother and explained the mistake. I also texted her the information for follow up with his PCP.  No reaction.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Ear pain, Headache, Hypersensitivity, Lethargy, Malaise
Clinical narrative: 1. Loud & heavy ringing in right ear.  Moderate ringing in left ear. This continues 1-2 times per day. 2. Headache/Malaise - Intermittent  An order was issued on 10/20/2021 and signed by organization leadership. This signed order mandated all employees to submit to vaccination for Covid-19.   I complied, with serious reservations and under duress, to this order on 10/25/2021. My voluntary submission to the Influenza vaccination run by the company on 11/1/2020 resulted in illness that caused another employee to grant me paid Medical sick leave a few days later to get over this negative allergic reaction. The Covid-19 vaccination has caused me to have headaches, lethargy, and most troubling - severe ringing in both ears that is painful and intiminitely debilitating. I could not report to the employer because of a hostile work environment created by this mandate.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Sick leave, Tinnitus
Clinical narrative: 1. Loud & heavy ringing in right ear.  Moderate ringing in left ear. This continues 1-2 times per day. 2. Headache/Malaise - Intermittent  An order was issued on 10/20/2021 and signed by organization leadership. This signed order mandated all employees to submit to vaccination for Covid-19.   I complied, with serious reservations and under duress, to this order on 10/25/2021. My voluntary submission to the Influenza vaccination run by the company on 11/1/2020 resulted in illness that caused another employee to grant me paid Medical sick leave a few days later to get over this negative allergic reaction. The Covid-19 vaccination has caused me to have headaches, lethargy, and most troubling - severe ringing in both ears that is painful and intiminitely debilitating. I could not report to the employer because of a hostile work environment created by this mandate.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Narrative:  Patient developed injection site pain following administration of Pfizer vaccine.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction, Paraesthesia
Clinical narrative: Narrative:  March 8, 2021 Patient received first COVID-19 vaccine (Pfizer) and the patient reported mild averse reaction of localized facial tingling sensation above right eyebrow. It started shortly after 13:30 and ended by 13:53 without intervention. Patient received 2nd Pfizer vaccine without incident on March 29, 2021.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Atelectasis, Blood bicarbonate increased, Blood fibrinogen, Blood gases abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Pfizer, dose #1 03/16, Pfizer, dose #2 07/27 pt cc: chest heaviness, dyspnea, chest pain exposure: unknown 7/29 pt cc; dyspnea 08/04 pt cc: diarrhea, headache, fever, 08/04 COVID swab, result: detected 08/04 ED admission with cc: dyspnea, cough, diarrhea x3 days 08/04 admitted to medicine dx: COVID-19 PNA 08/04 PT/APTT/INR 10.7/ 32.9/0.6 08/049 CXR impression: there are increased interstitial markings throughout both lungs, which could reflect chronic parenchymal disease, or an infectious/inflammatory process. There is a possible subtle focal opacity in the left mid lung. Short-term follow-up radiograph is recommended to confirm resolution. Focal opacities in the left lower lung suggest atelectasis. No pleural effusion or pneumothorax is identified. Cardiomediastinal contours appear stable. 08/04 ABG result: i-pH 7.48 iPCO2 44.0 iPO2 76 i-HCO 32.6 08/05 Ferritin result: 34.6 08/05 DDMINER result: 0.43 08/05 CRP result: 0.775 08/05 TToponin I <0.0160 08/06 ESR 24 08/06 FIBRINOGEN/ DDIMER results: 261/ 0.39 08/07 FIBRINOGEN/ DDIMER results: 261/ 0.61 08/07 ESR result: 18 08/07 pt discharged: 08/10 pt cc: improvement in symptoms and returned to work 08/09 08/10 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH increased, C-reactive protein normal, COVID-19, Chest X-ray abnormal, Chest discomfort
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Pfizer, dose #1 03/16, Pfizer, dose #2 07/27 pt cc: chest heaviness, dyspnea, chest pain exposure: unknown 7/29 pt cc; dyspnea 08/04 pt cc: diarrhea, headache, fever, 08/04 COVID swab, result: detected 08/04 ED admission with cc: dyspnea, cough, diarrhea x3 days 08/04 admitted to medicine dx: COVID-19 PNA 08/04 PT/APTT/INR 10.7/ 32.9/0.6 08/049 CXR impression: there are increased interstitial markings throughout both lungs, which could reflect chronic parenchymal disease, or an infectious/inflammatory process. There is a possible subtle focal opacity in the left mid lung. Short-term follow-up radiograph is recommended to confirm resolution. Focal opacities in the left lower lung suggest atelectasis. No pleural effusion or pneumothorax is identified. Cardiomediastinal contours appear stable. 08/04 ABG result: i-pH 7.48 iPCO2 44.0 iPO2 76 i-HCO 32.6 08/05 Ferritin result: 34.6 08/05 DDMINER result: 0.43 08/05 CRP result: 0.775 08/05 TToponin I <0.0160 08/06 ESR 24 08/06 FIBRINOGEN/ DDIMER results: 261/ 0.39 08/07 FIBRINOGEN/ DDIMER results: 261/ 0.61 08/07 ESR result: 18 08/07 pt discharged: 08/10 pt cc: improvement in symptoms and returned to work 08/09 08/10 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Diarrhoea, Dyspnoea, Fibrin D dimer, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Pfizer, dose #1 03/16, Pfizer, dose #2 07/27 pt cc: chest heaviness, dyspnea, chest pain exposure: unknown 7/29 pt cc; dyspnea 08/04 pt cc: diarrhea, headache, fever, 08/04 COVID swab, result: detected 08/04 ED admission with cc: dyspnea, cough, diarrhea x3 days 08/04 admitted to medicine dx: COVID-19 PNA 08/04 PT/APTT/INR 10.7/ 32.9/0.6 08/049 CXR impression: there are increased interstitial markings throughout both lungs, which could reflect chronic parenchymal disease, or an infectious/inflammatory process. There is a possible subtle focal opacity in the left mid lung. Short-term follow-up radiograph is recommended to confirm resolution. Focal opacities in the left lower lung suggest atelectasis. No pleural effusion or pneumothorax is identified. Cardiomediastinal contours appear stable. 08/04 ABG result: i-pH 7.48 iPCO2 44.0 iPO2 76 i-HCO 32.6 08/05 Ferritin result: 34.6 08/05 DDMINER result: 0.43 08/05 CRP result: 0.775 08/05 TToponin I <0.0160 08/06 ESR 24 08/06 FIBRINOGEN/ DDIMER results: 261/ 0.39 08/07 FIBRINOGEN/ DDIMER results: 261/ 0.61 08/07 ESR result: 18 08/07 pt discharged: 08/10 pt cc: improvement in symptoms and returned to work 08/09 08/10 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio, Interstitial lung disease, Lung opacity, Prothrombin time, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Pfizer, dose #1 03/16, Pfizer, dose #2 07/27 pt cc: chest heaviness, dyspnea, chest pain exposure: unknown 7/29 pt cc; dyspnea 08/04 pt cc: diarrhea, headache, fever, 08/04 COVID swab, result: detected 08/04 ED admission with cc: dyspnea, cough, diarrhea x3 days 08/04 admitted to medicine dx: COVID-19 PNA 08/04 PT/APTT/INR 10.7/ 32.9/0.6 08/049 CXR impression: there are increased interstitial markings throughout both lungs, which could reflect chronic parenchymal disease, or an infectious/inflammatory process. There is a possible subtle focal opacity in the left mid lung. Short-term follow-up radiograph is recommended to confirm resolution. Focal opacities in the left lower lung suggest atelectasis. No pleural effusion or pneumothorax is identified. Cardiomediastinal contours appear stable. 08/04 ABG result: i-pH 7.48 iPCO2 44.0 iPO2 76 i-HCO 32.6 08/05 Ferritin result: 34.6 08/05 DDMINER result: 0.43 08/05 CRP result: 0.775 08/05 TToponin I <0.0160 08/06 ESR 24 08/06 FIBRINOGEN/ DDIMER results: 261/ 0.39 08/07 FIBRINOGEN/ DDIMER results: 261/ 0.61 08/07 ESR result: 18 08/07 pt discharged: 08/10 pt cc: improvement in symptoms and returned to work 08/09 08/10 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Serum ferritin normal, Troponin normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/15, Pfizer, dose #1 03/16, Pfizer, dose #2 07/27 pt cc: chest heaviness, dyspnea, chest pain exposure: unknown 7/29 pt cc; dyspnea 08/04 pt cc: diarrhea, headache, fever, 08/04 COVID swab, result: detected 08/04 ED admission with cc: dyspnea, cough, diarrhea x3 days 08/04 admitted to medicine dx: COVID-19 PNA 08/04 PT/APTT/INR 10.7/ 32.9/0.6 08/049 CXR impression: there are increased interstitial markings throughout both lungs, which could reflect chronic parenchymal disease, or an infectious/inflammatory process. There is a possible subtle focal opacity in the left mid lung. Short-term follow-up radiograph is recommended to confirm resolution. Focal opacities in the left lower lung suggest atelectasis. No pleural effusion or pneumothorax is identified. Cardiomediastinal contours appear stable. 08/04 ABG result: i-pH 7.48 iPCO2 44.0 iPO2 76 i-HCO 32.6 08/05 Ferritin result: 34.6 08/05 DDMINER result: 0.43 08/05 CRP result: 0.775 08/05 TToponin I <0.0160 08/06 ESR 24 08/06 FIBRINOGEN/ DDIMER results: 261/ 0.39 08/07 FIBRINOGEN/ DDIMER results: 261/ 0.61 08/07 ESR result: 18 08/07 pt discharged: 08/10 pt cc: improvement in symptoms and returned to work 08/09 08/10 clinically resolved
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative: Patient reported mild headache following administration of Pfizer covid vaccine. Patient required no intervention and was able to be released.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Narrative: Patient reported headache and nausea following 1st dose of pfizer covid vaccine. Patient was able to released with no intervention.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Narrative:  Patient developed nausea and vomiting following administration of second moderna covid vaccine. Was sent to ER for follow up where the patient improved and was subsequently discharged.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative: Patient reported headache following administration of 1st dose of pfizer covid vaccine. Patient was released with no intervention.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 01/14, Pfizer, dose #1 02/04, Pfizer dose #2 08/04 pt cc: cough, rhinorrhea, fatigue, headache, myalgias, nocturnal dyspnea exposure: unknown 08/05 COVID swab, result: detected 08/05 - 08/12 pt's symptoms continued 08/05 CXR impression: Chronic right pleural effusion and atelectatic changes in the right lung base, stable from previous examination. The remaining visualized lung fields are clear. 08/09 pt admitted in ED dx: COVID PNA LOS: 1 day 08/09 TROPONIN I 0.120 08/09 BNP 2251 08/09 CXR impression: The heart shadow is normal in size. Small right pleural effusion and adjacent atelectasis/consolidation is stable from prior. No new consolidation or pneumothorax. Note that groundglass opacities, as can occur with viral pneumonia, may not be visible on plan film 08/10 CT Chest impression: Scattered bilateral patchy groundglass opacities and groundglass nodules, left greater than right, can be seen in COVID-19 pneumonia. Small right pleural effusion. Mildly progressive right middle lobe consolidation. Recommend follow-up. 08/12 Clinically resolved 08/12 SARS-COV-2 LINGEAGE result: B.1.617.2 08/12 SARS-COV-2 clade results: 21A DELTA 08/26 COVID swab, result detected